Novo Nordisk ASMEX:NVON -0.60%76 OCF Yield % is 8.48 as of Jun. 26, 2026, which is 61% above its 10-year median of 5.26. GuruFocus rates MEX:NVON with a GF Score™ of 76/100 and a GF Value™ of MXN2,387.52 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Novo Nordisk AS ranks better than 73.53% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Novo Nordisk AS OCF Yield % Related Terms
Novo Nordisk AS OCF Yield % Historical Data
* Premium members only.
The historical data trend for Novo Nordisk AS's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:NVON vs LLY, JNJ, ABBV: OCF Yield % Comparison
For the Drug Manufacturers - General subindustry, Novo Nordisk AS's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novo Nordisk AS OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Novo Nordisk AS's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Novo Nordisk AS's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novo Nordisk AS (MEX:NVON) has a OCF Yield % of 8.48 as of Jun. 26, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Novo Nordisk AS and its competitors. This is 61% above median its historical median of 5.26. Over the past decade, Novo Nordisk AS's OCF Yield % has ranged from 2.08 to 11.71. According to the industry distribution chart, Novo Nordisk AS ranks #266 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 26.5%.
Is Novo Nordisk AS's OCF Yield % too high?
Novo Nordisk AS's current OCF Yield % of 8.48 is 61% above median its 10-year median of 5.26. Over the past 10 years, this metric has ranged from a low of 2.08 to a high of 11.71. The Drug Manufacturers industry median OCF Yield % is 3.61. Novo Nordisk AS's value of 8.48 is 134.9% above this industry median. Based on the distribution chart, Novo Nordisk AS ranks #266 out of 1005 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Novo Nordisk AS has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Novo Nordisk AS's OCF Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Novo Nordisk AS ranks #266 out of 1005 companies for OCF Yield %. This puts Novo Nordisk AS in the upper half of its industry. The industry median OCF Yield % is 3.61. Novo Nordisk AS's value of 8.48 is 134.9% above this benchmark. Historically, Novo Nordisk AS's own OCF Yield % has ranged from 2.08 to 11.71 over the past decade. While the company's 10-year median is 5.26 vs. the industry median of 3.61, Novo Nordisk AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.61, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novo Nordisk AS's current OCF Yield % of 8.48 is 134.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Novo Nordisk AS and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novo Nordisk AS's current OCF Yield % is 8.48, which is 61% above median its own 10-year median of 5.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novo Nordisk AS stock overvalued right now?
Based on GuruFocus' analysis, Novo Nordisk AS (MEX:NVON) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN2,387.52, compared to a current price of MXN831.50 — trading 65.2% below its estimated fair value. The current OCF Yield % is 8.48, which is 61% above median its 10-year median of 5.26 and 134.9% above the Drug Manufacturers industry median of 3.61. Novo Nordisk AS's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Novo Nordisk AS (MEX:NVON), the current OCF Yield % is 8.48 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novo Nordisk AS (MEX:NVON) Overvalued in 2026?
Based on GuruFocus' analysis, Novo Nordisk AS stock appears to be undervalued.
The current stock price of MXN831.50 is trading 65.2% below its estimated GF Value™ of MXN2,387.52.
GuruFocus considers Novo Nordisk AS to be Significantly Undervalued.
Key valuation signals for MEX:NVON:
OCF Yield %: 8.48 (61% above median its 10-year median of 5.26)
GF Value™: MXN2,387.52 vs. price of MXN831.50 (65.2% below fair value)
Industry Position: 134.9% above the Drug Manufacturers median (#266 of 1005)
No single metric tells the full story. See the MEX:NVON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
76GF Score
Get the complete analysis for MEX:NVON
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:NVON has been successfully added to your 
